Keyphrases
Kinetic Study
100%
Hexokinase
100%
Metabolic Study
100%
Bisphosphonates
100%
Trypanosoma Cruzi (T. cruzi)
100%
Epimastigote
33%
Amino Acids
16%
Order of Magnitude
16%
Kinetic Analysis
16%
Liver
16%
Clinically Significant
16%
Detailed Chemical Kinetics
16%
Glycolytic Pathway
16%
Novel Class
16%
Carbon Source
16%
Glucose Consumption
16%
Energy Sources
16%
Selective Inhibitor
16%
Specific Inhibitor
16%
Permeabilized
16%
Mixed Inhibition
16%
IC50 Value
16%
ATP-dependent
16%
Novel Family
16%
Potent Inhibitor
16%
Etiological Agents
16%
Growth Inhibition
16%
Glucose-6-phosphatase (G6Pase)
16%
Chagas Disease
16%
Sterol Composition
16%
Peroxisome
16%
Geranylgeranyl Diphosphate Synthase
16%
Anti-T. Cruzi Agents
16%
Digitonin
16%
T. Cruzi Epimastigotes
16%
Metabolic Shift
16%
Inorganic Pyrophosphate
16%
Intracellular Amastigotes
16%
Glycosome
16%
Non-competitive Inhibitor
16%
Stable Analogue
16%
Metabolically Stable
16%
Amastigote
16%
Biochemistry, Genetics and Molecular Biology
Hexokinase
100%
Trypanosoma Cruzi
100%
Epimastigote
100%
Enzyme
66%
Pyrophosphate
66%
Amino Acids
33%
Adenosine Triphosphate
33%
Synthase
33%
Kinetics
33%
IC50
33%
Growth Inhibition
33%
Sterol
33%
Glucose 6-Phosphate
33%
Peroxisome
33%
Glycosome
33%
Amastigote
33%
Digitonin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
100%
Trypanosoma Cruzi
100%
Hexokinase
100%
Epimastigote
50%
IC50
16%
Amino Acid
16%
Adenosine Triphosphate
16%
Chagas Disease
16%
Pyrophosphate
16%
Sterol
16%
Geranyltransferase
16%
Digitonin
16%
Glucose 6 Phosphate
16%
Amastigote
16%